Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 14451-14500 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04180449
DYsphagiA in interMedIate Care UnitS
N/A
Active, not recruiting
1,400 participants
Started: Feb 14, 2020 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT03892694
Metered Cryospray for the Treatment of Patients With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
NA
Active, not recruiting
32 participants
Started: Feb 14, 2020 · Completed: Jun 1, 2024
2 conditions
1 sponsor
2 locations
NCT04276532
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus
NA
Active, not recruiting
780 participants
Started: Feb 13, 2020 · Completed: Feb 12, 2030
3 conditions
6 sponsors
1 location
NCT04007744
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
36 participants
Started: Feb 13, 2020 · Completed: Nov 15, 2026
22 conditions
1 sponsor
3 locations
NCT04248829
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)
PHASE3
Active, not recruiting
393 participants
Started: Feb 13, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
80 locations
NCT04189614
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
65 participants
Started: Feb 13, 2020 · Completed: Dec 31, 2025
2 conditions
2 sponsors
26 locations
NCT04191096
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)
PHASE3
Active, not recruiting
1,251 participants
Started: Feb 12, 2020 · Completed: Feb 2, 2026
1 condition
1 sponsor
234 locations
NCT04953715
Microbiome and Immunosuppression: The Mission Study
N/A
Active, not recruiting
140 participants
Started: Feb 12, 2020 · Completed: Jan 1, 2033
2 conditions
2 sponsors
2 locations
NCT04270773
Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women
PHASE4
Active, not recruiting
158 participants
Started: Feb 12, 2020 · Completed: Dec 30, 2024
2 conditions
2 sponsors
1 location
NCT04273893
Lymphocyte Depletion and Change in Lymphocyte Functionality
NA
Active, not recruiting
55 participants
Started: Feb 12, 2020 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT04216953
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
PHASE1/PHASE2
Active, not recruiting
320 participants
Started: Feb 12, 2020 · Completed: Feb 1, 2027
1 condition
1 sponsor
6 locations
NCT04285398
Prospective Natural History Study of Retinitis Pigmentosa
NA
Active, not recruiting
82 participants
Started: Feb 12, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT04211337
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
PHASE3
Active, not recruiting
291 participants
Started: Feb 11, 2020 · Completed: Feb 28, 2026
1 condition
2 sponsors
143 locations
NCT04165941
Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients with Newly Diagnosed Glioblastoma
PHASE1
Active, not recruiting
22 participants
Started: Feb 11, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04069312
Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
PHASE4
Active, not recruiting
1,032 participants
Started: Feb 11, 2020 · Completed: May 1, 2026
2 conditions
3 sponsors
27 locations
NCT04249492
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL
NA
Active, not recruiting
244 participants
Started: Feb 11, 2020 · Completed: Jun 30, 2024
2 conditions
2 sponsors
12 locations
NCT04230369
Internet-delivered CBT for Anxiety Related to Asthma
NA
Active, not recruiting
90 participants
Started: Feb 11, 2020 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT04166721
WaKING: Wnt and checKpoint INhibition in Gastric Cancer
PHASE1/PHASE2
Active, not recruiting
52 participants
Started: Feb 11, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04268498
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
PHASE2
Active, not recruiting
310 participants
Started: Feb 11, 2020 · Completed: Feb 1, 2027
1 condition
3 sponsors
7 locations
NCT04144387
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.
NA
Active, not recruiting
395 participants
Started: Feb 11, 2020 · Completed: Dec 31, 2028
1 condition
1 sponsor
90 locations
NCT04267744
Remote Monitoring of Multiple Indicators of Heart Failure
NA
Active, not recruiting
165 participants
Started: Feb 11, 2020 · Completed: Aug 1, 2024
1 condition
3 sponsors
1 location
NCT04248582
Cryotherapy for Locally Advanced Esophageal Cancer
PHASE1
Active, not recruiting
14 participants
Started: Feb 11, 2020 · Completed: Jul 1, 2025
1 condition
2 sponsors
1 location
NCT04158648
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
PHASE3
Active, not recruiting
73 participants
Started: Feb 10, 2020 · Completed: Dec 31, 2025
3 conditions
1 sponsor
22 locations
NCT04254250
Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation
N/A
Active, not recruiting
386 participants
Started: Feb 10, 2020 · Completed: Feb 10, 2026
1 condition
1 sponsor
2 locations
NCT04042701
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
115 participants
Started: Feb 10, 2020 · Completed: Oct 1, 2025
2 conditions
3 sponsors
30 locations
NCT03914300
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
PHASE2
Active, not recruiting
9 participants
Started: Feb 10, 2020 · Completed: Dec 17, 2025
9 conditions
1 sponsor
33 locations
NCT04544462
ANXA5 M2 Haplotyping in IVF Patients and Embryos
N/A
Active, not recruiting
500 participants
Started: Feb 10, 2020 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT04243499
First-in-Human Study of ICT01 in Patients With Advanced Cancer
PHASE1/PHASE2
Active, not recruiting
292 participants
Started: Feb 10, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
29 locations
NCT04042025
Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi
PHASE3
Active, not recruiting
85 participants
Started: Feb 10, 2020 · Completed: Dec 31, 2035
4 conditions
1 sponsor
31 locations
NCT04169841
Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment
PHASE2
Active, not recruiting
270 participants
Started: Feb 10, 2020 · Completed: Aug 10, 2027
1 condition
2 sponsors
8 locations
NCT03631745
Delivering Church-based Interventions to Reduce Stigma and Mental Health Treatment Disparities Among Latinos
NA
Active, not recruiting
1,713 participants
Started: Feb 9, 2020 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04037605
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
EARLY_PHASE1
Active, not recruiting
5 participants
Started: Feb 9, 2020 · Completed: Jun 24, 2026
1 condition
1 sponsor
1 location
NCT04253691
Sleep Intervention for Chronic Insomnia Using Virtual Reality Pilot Study
NA
Active, not recruiting
30 participants
Started: Feb 9, 2020 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT03819894
Hs-cTn - Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women
NA
Active, not recruiting
24,000 participants
Started: Feb 8, 2020 · Completed: Mar 31, 2025
3 conditions
2 sponsors
1 location
NCT04262921
French COVID Cohort
N/A
Active, not recruiting
4,415 participants
Started: Feb 8, 2020 · Completed: Aug 7, 2025
1 condition
1 sponsor
98 locations
NCT04253184
Micra AV Transcatheter Pacing System Post-Approval Registry
N/A
Active, not recruiting
802 participants
Started: Feb 8, 2020 · Completed: Jan 30, 2026
1 condition
1 sponsor
89 locations
NCT04267302
Baby Item Learning and Development Study
NA
Active, not recruiting
100 participants
Started: Feb 7, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04266080
Game-Based Physical Activity in Childhood Cancer Survivors
NA
Active, not recruiting
48 participants
Started: Feb 7, 2020 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT04197141
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
PHASE2
Active, not recruiting
58 participants
Started: Feb 7, 2020 · Completed: Mar 31, 2027
1 condition
3 sponsors
3 locations
NCT04324229
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
NA
Active, not recruiting
80 participants
Started: Feb 7, 2020 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03719092
High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
NA
Active, not recruiting
62 participants
Started: Feb 7, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04278131
BS01 in Patients With Retinitis Pigmentosa
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Feb 6, 2020 · Completed: Dec 30, 2029
1 condition
1 sponsor
1 location
NCT04189172
MiDura-Study (Neuro-Patch in Duraplasty)
N/A
Active, not recruiting
328 participants
Started: Feb 6, 2020 · Completed: Jan 31, 2026
10 conditions
1 sponsor
4 locations
NCT04223401
Prehabilitation for Gastrectomy
NA
Active, not recruiting
128 participants
Started: Feb 6, 2020 · Completed: Dec 31, 2023
1 condition
3 sponsors
2 locations
NCT04154956
SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients
PHASE3
Active, not recruiting
389 participants
Started: Feb 6, 2020 · Completed: Mar 31, 2026
1 condition
1 sponsor
169 locations
NCT04098003
Investigation of the Gut Microbiome and Statin Response
PHASE4
Active, not recruiting
62 participants
Started: Feb 6, 2020 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT04235491
Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED)
N/A
Active, not recruiting
37,000 participants
Started: Feb 6, 2020 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT04197856
Direct Information to At-risk Relatives
NA
Active, not recruiting
490 participants
Started: Feb 6, 2020 · Completed: Jul 1, 2025
5 conditions
4 sponsors
1 location
NCT06780384
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors
N/A
Active, not recruiting
5,000 participants
Started: Feb 5, 2020 · Completed: Aug 31, 2025
1 condition
2 sponsors
2 locations
NCT04024462
A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer
PHASE3
Active, not recruiting
200 participants
Started: Feb 5, 2020 · Completed: Feb 8, 2026
1 condition
1 sponsor
18 locations
Previous
1
More pages
287
288
289
290
291
292
293
More pages
431
Next